CA2266659A1 - Pretreatment with growth factors to protect against cns damage - Google Patents
Pretreatment with growth factors to protect against cns damage Download PDFInfo
- Publication number
- CA2266659A1 CA2266659A1 CA002266659A CA2266659A CA2266659A1 CA 2266659 A1 CA2266659 A1 CA 2266659A1 CA 002266659 A CA002266659 A CA 002266659A CA 2266659 A CA2266659 A CA 2266659A CA 2266659 A1 CA2266659 A1 CA 2266659A1
- Authority
- CA
- Canada
- Prior art keywords
- growth factors
- mammal
- growth factor
- fgf
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Magnetic Heads (AREA)
- Chemical Vapour Deposition (AREA)
- Carbon And Carbon Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3048596P | 1996-11-15 | 1996-11-15 | |
US60/030,485 | 1996-11-15 | ||
PCT/CA1997/000859 WO1998022127A1 (en) | 1996-11-15 | 1997-11-14 | Pretreatment with growth factors to protect against cns damage |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2266659A1 true CA2266659A1 (en) | 1998-05-28 |
Family
ID=21854421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002266659A Abandoned CA2266659A1 (en) | 1996-11-15 | 1997-11-14 | Pretreatment with growth factors to protect against cns damage |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0941109A1 (ja) |
JP (1) | JP2001504123A (ja) |
AU (1) | AU5043398A (ja) |
CA (1) | CA2266659A1 (ja) |
NO (1) | NO992364L (ja) |
WO (1) | WO1998022127A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0996456A4 (en) | 1997-08-04 | 2003-07-09 | Univ California | PROCESS FOR TREATING NEUROLOGICAL DEFICITS |
US7795202B2 (en) * | 1997-08-04 | 2010-09-14 | Neurorepair, Inc. | Methods for treating a neurological disorder by peripheral administration of a transforming growth factor alpha (TGF-a) |
JP2002543096A (ja) | 1999-04-26 | 2002-12-17 | ステム セル ファーマシューティカルズ,インコーポレーテッド | TGF−αポリペプチド、機能性断片およびそれらの利用法 |
US20020099008A1 (en) | 1999-04-26 | 2002-07-25 | Daniel R. Twardzik | Method for stimulating hematopoiesis using tgf-alpha |
US20020193301A1 (en) | 1999-08-19 | 2002-12-19 | Stem Cell Pharmaceuticals, Inc. | TGF-alpha polypeptides, functional fragments and methods of use therefor |
US6815418B2 (en) | 1999-08-19 | 2004-11-09 | Kaleidos Pharma, Inc. | TGF-α polypeptides, functional fragments and methods of use therefor |
US6677307B2 (en) | 1999-08-19 | 2004-01-13 | Kaleidos Pharma, Inc. | TGF-α polypeptides, functional fragments and methods of use therefor |
WO2003060082A2 (en) * | 2002-01-14 | 2003-07-24 | The Board Of Trustees Of The University Of Illinois | Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU697894B2 (en) * | 1993-11-09 | 1998-10-22 | Neurospheres Holdings Ltd | (In situ) modification and manipulation of stem cells of the central nervous system |
CN1170435A (zh) * | 1994-11-14 | 1998-01-14 | 纽罗斯菲里斯控股有限公司 | 神经干细胞增殖的调节 |
WO1997035605A1 (en) * | 1996-03-26 | 1997-10-02 | Neurospheres Holdings Ltd. | Manipulation of mitotically active cells of the hippocampal region of the brain |
-
1997
- 1997-11-14 EP EP97913033A patent/EP0941109A1/en not_active Withdrawn
- 1997-11-14 CA CA002266659A patent/CA2266659A1/en not_active Abandoned
- 1997-11-14 WO PCT/CA1997/000859 patent/WO1998022127A1/en not_active Application Discontinuation
- 1997-11-14 JP JP52302998A patent/JP2001504123A/ja active Pending
- 1997-11-14 AU AU50433/98A patent/AU5043398A/en not_active Abandoned
-
1999
- 1999-05-14 NO NO992364A patent/NO992364L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2001504123A (ja) | 2001-03-27 |
AU5043398A (en) | 1998-06-10 |
NO992364D0 (no) | 1999-05-14 |
EP0941109A1 (en) | 1999-09-15 |
WO1998022127A1 (en) | 1998-05-28 |
NO992364L (no) | 1999-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Knuckey et al. | Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia | |
Timmer et al. | Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms | |
US8158578B2 (en) | Methods for treating neurological deficits | |
Sapieha et al. | Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury | |
Gravel et al. | Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons | |
ES2546093T3 (es) | VEGF para utilizar en el tratamiento de trastornos del sistema nervioso central | |
Vidal-Sanz et al. | Death and neuroprotection of retinal ganglion cells after different types of injury | |
Blesch et al. | Axonal responses to cellularly delivered NT-4/5 after spinal cord injury | |
Chandross et al. | TNFα inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication | |
US8673594B2 (en) | Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis | |
Ban et al. | Intraspinal cord graft of autologous activated Schwann cells efficiently promotes axonal regeneration and functional recovery after rat's spinal cord injury | |
Johnston et al. | Trophic factor secreting kidney cell lines: in vitro characterization and functional effects following transplantation in ischemic rats | |
Cunningham et al. | Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease | |
Rohrer et al. | Neurotrophin receptor TrkB activation is not required for the postnatal survival of retinal ganglion cells in vivo | |
US20030129164A1 (en) | Expression of glial-derived neurotrophic factor for treatment of diseases of the eye | |
CA2266659A1 (en) | Pretreatment with growth factors to protect against cns damage | |
Kramer et al. | P75 nerve growth factor receptor is important for retrograde transport of neurotrophins in adult cholinergic basal forebrain neurons | |
KR100765496B1 (ko) | 히레귤린 베타1의 egf-성 도메인 펩타이드를 암호화하는dna 서열을 포함하는 재조합 아데노바이러스 및 이를포함하는 신경세포 분화 및 재생용 약학 조성물 | |
WO1998022127A9 (en) | Pretreatment with growth factors to protect against cns damage | |
Fischer | Nerve growth factor reverses spatial memory impairments in aged rats | |
AU5393001A (en) | Pretreatment with growth factors to protect against CNS damage | |
US20010007657A1 (en) | Compositions and methods for manipulating glial progenitor cells and treating neurological deficits | |
Sukhov et al. | Evidence that perihypoglossal neurons involved in vestibular‐auditory and gaze control functions respond to nerve growth factor | |
KR101186218B1 (ko) | 히레귤린 베타1의 egf-성 도메인 펩타이드의 용도 | |
SAUER et al. | 6-hydroxydopamine lesion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |